Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$5.07 - $8.44 $58,097 - $96,713
11,459 New
11,459 $62,000
Q2 2023

Jul 18, 2023

BUY
$6.19 - $8.78 $990 - $1,404
160 Added 0.76%
21,351 $143,000
Q1 2023

Apr 13, 2023

BUY
$7.8 - $10.11 $24,398 - $31,624
3,128 Added 17.32%
21,191 $187,000
Q4 2022

Jan 23, 2023

BUY
$6.26 - $9.34 $59,232 - $88,375
9,462 Added 110.01%
18,063 $0
Q3 2022

Oct 26, 2022

BUY
$6.5 - $12.67 $55,906 - $108,974
8,601 New
8,601 $61,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.